However, in contrast to primary AML patient samples, RUNX1/ETO-selected progenitor cells fail to induce leukemia development in immunocompromised NOD/SCID mice, thereby suggesting that additional genetic events are necessary for leukemia development (Mulloy et al., 2002, 2003). The gene discussed is RUNX1; the disease is leukemia.